| Ytd | 124.00% | |
| 1y | -52.00% |
| Open | 1.75 | Prev Close | 1.77 | Low | 1.67 | High | 1.80 | Mkt Cap | 7.44M |
| Vol | 70.66K | Avg Vol | 65.93K | EPS | -10.24 | P/E | N/A | Forward P/E | -2.27 |
| Beta | 1.75 | Short Ratio | 10.06 | Inst. Own | 86.03% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-09 | 50-d Avg | 4.50 | 200-d Avg | 6.44 | 1yr Est | 18.00 |
SKYE News
Gainers Redhill Biopharma (NASDAQ:RDHL) shares increased by 96.7% to $1.3 during Monday's pre-m
Skye Bioscience shares rise 6% after hours on a $22M equity purchase agreement and warrant issuance.
Entry into a Material Definitive Agreement. As previously disclosed on the Current Report on Form 8-
Skye Bioscience (NASDAQ: SKYE) and privately held Redx announced a definitive transaction agreement
HIVE Digital Technologies Ltd (NASDAQ: HIVE) rose in pre-market trading due to its subsidiary's
Skye Bioscience, Inc. (SKYE) M&A Call Prepared Remarks Transcript
Combined company to trade on Nasdaq and operate as Fibrx Therapeutics, a fibrosis-focused company le
Combined company to trade on Nasdaq and operate as Fibrx Therapeutics, a fibrosis-focused company le
Gainers Doximity (NYSE:DOCS) stock rose 85.1% to $38.25 during Friday's pre-market session. The
Skye Bioscience, Inc. (NASDAQ: SKYE - Get Free Report)'s share price was up 2.8% during mid-day trad
On June 18, 2026, the Company received approval from the Staff to transfer the listing of the Compan
Skye Bioscience, Inc. (NASDAQ:SKYE), a clinical-stage biotechnology company focused on unlocking new
SAN DIEGO, May 20, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (NASDAQ: SKYE), a clinical-stage b
SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye” or the “Com
Skye Bioscience (NASDAQ:SKYE) reported quarterly losses of $(0.32) per share which missed the analys
SAN DIEGO, May 11, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye” or the “Com
NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is
Skye Bioscience, Inc. (NASDAQ:SKYE) ("Skye") a clinical-stage biotechnology company focused
SAN DIEGO, April 07, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinic
Skye Bioscience, Inc. (NASDAQ:SKYE) ("Skye") a clinical-stage biotechnology company focused
Topline safety and pharmacokinetic data expected in Q4 2026; an independent Data Monitoring Committe
Domo Inc (DOMO) stock jumped 48.8% in pre-market trading after beating Q4 earnings expectations by 1
Skye Bioscience, Inc. (SKYE) Q4 2025 Earnings Call Transcript
Skye Bioscience (NASDAQ:SKYE) reported quarterly losses of $(0.36) per share which missed the analys
SAN DIEGO, March 10, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (NASDAQ: SKYE) (“Skye” or the “C
SAN DIEGO, March 05, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clini
Shares of Skye Bioscience, Inc. (NASDAQ: SKYE - Get Free Report) have been given a consensus recomme
Skye Bioscience, Inc. (NASDAQ: SKYE) on Monday shared interim 52-week data from the combination ther
22.3% total weight loss at 52 weeks with nimacimab (200 mg dose) + semaglutide (2.4 mg) combination
SAN DIEGO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinica
SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinica
NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is i
Shares of Skye Bioscience, Inc. (NASDAQ: SKYE - Get Free Report) have been given an average recommen
Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market ses